Related Experiment Video
Updated: Jun 13, 2025
Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
Published on: July 31, 2016
Perioperative Management for Port Catheter Procedures in Pediatric Patients with Severe Hemophilia and Inhibitors
Anna Woestemeier1, Silvia Horneff2, Vincent Marlon Lüder1
1Department for General, Visceral, Thoracic and Vascular Surgery, University Hospital of Bonn, Bonn, Germany.
Insights
Port catheter surgery is safe for pediatric hemophilia patients with inhibitors. A multidisciplinary team approach is crucial for successful perioperative management and outcomes in these complex cases.
Area of Science:
- Pediatric Surgery
- Hematology
- Hemophilia Management
Background:
- Hemophilia A/B with inhibitors presents unique surgical challenges.
- Assessing perioperative management and outcomes is critical for patient safety.
Purpose of the Study:
- To compare surgical outcomes in pediatric hemophilia patients with inhibitors versus nonhemophilic controls.
- To evaluate the safety and efficacy of perioperative protocols in this specific patient group.
Main Methods:
- A retrospective comparison of 69 port catheter operations in hemophilic patients with inhibitors against 51 procedures in a control group.
- Standardized use of recombinant activated factor VII for perioperative bleeding prevention in hemophilic patients.
Main Results:
- No significant differences in perioperative management (transfusions, surgery duration) between groups.
- Significantly longer hospital stays observed in hemophilic patients with inhibitors.
- No statistically significant differences in secondary bleeding or surgical complications.
Conclusions:
- Port catheter insertion and removal are safe procedures for pediatric patients with hemophilia and inhibitors.
- Highlights the necessity of a coordinated, multidisciplinary team approach for optimal patient care.
Background:
The objective of this systematic study was to assess the perioperative management and outcome of surgery in pediatric patients with hemophilia A/B and inhibitors compared to nonhemophilic pediatric patients.
Methods:
The surgical outcome of 69 port catheter operations in patients with hemophilia who developed inhibitory antibodies against the administered factor was compared to 51 procedures in the control group. In the patients with hemophilia and inhibitors, a standardized protocol for recombinant activated factor VII was used to prevent perioperative bleeding.
Results:
Hemophilic pediatric patients with inhibitors showed no significant differences in perioperative management (blood transfusion: p = 0.067, duration of surgery: p = 0.69; p = 0.824) in comparison to patients without hemophilia. The length of hospital stay was significantly longer in pediatric patients with hemophilia and inhibitors (20 days vs. 4 days for insertion; 12 days vs. 1 day for explantation). Moreover, no statistically significant difference was found for secondary bleeding (three patients with hemophilia vs. none in the control group; p = 0.11) or surgical complications (five hemophilia patients vs. none with grade I complication; one hemophilia patient vs. none with grade II complications; p = 0.067).
Conclusion:
This study has demonstrated that port catheter insertion and removal is safe in these patients. Moreover, it shows the importance of a coordinated approach with a multidisciplinary team.
More Related Videos
Related Concept Videos
01:27Parentral Nutrition: Centeral and Peripheral Parental Nutrition
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
01:28Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...